What is ClinOne?
Founded in 2013 and headquartered in Needham, Massachusetts, ClinOne provides a comprehensive software ecosystem dedicated to clinical trial enrollment, patient retention, and research site compliance. The company addresses the persistent challenges of trial management by placing essential research details directly into the hands of stakeholders. By digitizing and simplifying the participant experience, ClinOne reduces the administrative burden on research sites while simultaneously improving data integrity and patient engagement. Its market position is defined by its focus on the intersection of healthcare technology and clinical operations, where it acts as a catalyst for more efficient, transparent, and patient-friendly research environments.
How much funding has ClinOne raised?
ClinOne has raised a total of $5M across 1 funding round:
Series A
$5M
Series A (2023): $5M with participation from First Trust Capital Partners, Highpoint Ventures, Boulder Ventures, and CU Healthcare Innovation Fund
Key Investors in ClinOne
First Trust Capital Partners
First Trust Capital Partners specializes in early and growth stage investments, with a strong emphasis on the financial services and healthcare technology sectors.
Highpoint Ventures
Highpoint Ventures is a Colorado-based firm focused on supporting early-stage healthcare and technology disruptors through strategic guidance and capital.
Boulder Ventures
Boulder Ventures is a venture capital firm specializing in IT and biotech investments, with a proven track record of supporting startups through to IPO.
What's next for ClinOne?
With the successful closure of this major strategic investment, ClinOne is well-positioned to expand its technological footprint and deepen its market penetration. The company is expected to leverage this capital to enhance its software capabilities, potentially integrating advanced analytics and automated compliance features to further differentiate its offering in a competitive landscape. Strategic priorities likely include scaling its enterprise-level support infrastructure and fostering deeper partnerships with global pharmaceutical companies and contract research organizations. As the industry shifts toward more agile and digital-first trial methodologies, ClinOne's focus on user-centric design and operational efficiency will be instrumental in maintaining its competitive advantage and driving long-term value for its stakeholders.
See full ClinOne company page